EE04878B1 - šhendid maop?hja kahjustunud relaksatsiooni raviks, nende valmistamismeetod, farmatseutiline kompositsioon ja selle valmistamismeetod - Google Patents

šhendid maop?hja kahjustunud relaksatsiooni raviks, nende valmistamismeetod, farmatseutiline kompositsioon ja selle valmistamismeetod

Info

Publication number
EE04878B1
EE04878B1 EEP200200694A EEP200200694A EE04878B1 EE 04878 B1 EE04878 B1 EE 04878B1 EE P200200694 A EEP200200694 A EE P200200694A EE P200200694 A EEP200200694 A EE P200200694A EE 04878 B1 EE04878 B1 EE 04878B1
Authority
EE
Estonia
Prior art keywords
preparation
compounds
treatment
pharmaceutical composition
gastrointestinal lesions
Prior art date
Application number
EEP200200694A
Other languages
English (en)
Estonian (et)
Inventor
Van Emelen Kristof
Frans Leopold De Bruyn Marcel
Jesus Alc βzar-Vaca Manuel
Ignacio Andr�s-Gil Jos�
Javier Fern βndez-Gadea Francisco
Encarnacion Matesanz-Ballesteros Maria
Manuel Bartolom�-Nebreda Jos�
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of EE200200694A publication Critical patent/EE200200694A/xx
Publication of EE04878B1 publication Critical patent/EE04878B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
EEP200200694A 2000-06-22 2001-06-13 šhendid maop?hja kahjustunud relaksatsiooni raviks, nende valmistamismeetod, farmatseutiline kompositsioon ja selle valmistamismeetod EE04878B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00202180 2000-06-22
PCT/EP2001/006749 WO2001098306A1 (en) 2000-06-22 2001-06-13 Compounds for treating impaired fundic relaxation

Publications (2)

Publication Number Publication Date
EE200200694A EE200200694A (et) 2004-06-15
EE04878B1 true EE04878B1 (et) 2007-08-15

Family

ID=8171674

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200694A EE04878B1 (et) 2000-06-22 2001-06-13 šhendid maop?hja kahjustunud relaksatsiooni raviks, nende valmistamismeetod, farmatseutiline kompositsioon ja selle valmistamismeetod

Country Status (34)

Country Link
US (2) US7081453B2 (is)
EP (1) EP1296987B1 (is)
JP (1) JP4911860B2 (is)
KR (1) KR100821107B1 (is)
CN (2) CN100516066C (is)
AR (1) AR032158A1 (is)
AT (1) ATE312104T1 (is)
AU (1) AU783292B2 (is)
BG (1) BG65895B1 (is)
BR (1) BR0111859B1 (is)
CA (1) CA2410233C (is)
CZ (1) CZ305005B6 (is)
DE (1) DE60115647T2 (is)
EA (1) EA005760B1 (is)
EE (1) EE04878B1 (is)
EG (1) EG24462A (is)
ES (1) ES2254467T3 (is)
HK (1) HK1057896A1 (is)
HR (1) HRP20020988B1 (is)
HU (1) HU227398B1 (is)
IL (2) IL153559A0 (is)
IS (1) IS2618B (is)
JO (1) JO2352B1 (is)
MX (1) MXPA02012844A (is)
MY (1) MY155267A (is)
NO (1) NO328547B1 (is)
NZ (1) NZ522519A (is)
PA (1) PA8519601A1 (is)
PL (1) PL201656B1 (is)
SA (1) SA01220442B1 (is)
SK (1) SK287730B6 (is)
UA (1) UA74576C2 (is)
WO (1) WO2001098306A1 (is)
ZA (1) ZA200210303B (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0201404A3 (en) 1999-06-02 2005-02-28 Janssen Pharmaceutica Nv Aminoalkyl substituted benzodioxan, benzofuran or benzopyran derivatives, pharmaceutical compositions containing them and their use and process for their preparations
CZ20014167A3 (cs) 1999-06-02 2002-06-12 Janssen Pharmaceutica N. V. Pyrrolidinylem, piperidinylem nebo homopiperidinylem substituované deriváty benzodioxanu, benzofuranu nebo benzopyranu
JO2352B1 (en) * 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus
JO2654B1 (en) * 2000-09-04 2012-06-17 شركة جانسين فارماسوتيكا ان. في Multiple aryl caroxa amides are useful as lipid - lowering agents
JO2409B1 (en) 2000-11-21 2007-06-17 شركة جانسين فارماسوتيكا ان. في Second-phenyl carboxy amides are useful as lipid-lowering agents
AU2004233863B2 (en) 2003-04-24 2010-06-17 Incyte Holdings Corporation Aza spiro alkane derivatives as inhibitors of metalloproteases
JP4896476B2 (ja) * 2005-09-16 2012-03-14 広栄化学工業株式会社 メチルオキシメチルアミノピリジン誘導体及びその製造方法
US7999107B2 (en) 2007-01-31 2011-08-16 Merck Sharp & Dohme Corp. Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators
MX2009011923A (es) * 2007-05-10 2009-11-18 Amr Technology Inc Tetrahidrobenzo-1,4-diazepinas aril- y heteroaril-sustituidas y uso de las mismas para bloquear reabsorcion de norepinefrina, dopamina y serotonina.
EA027324B1 (ru) 2011-11-11 2017-07-31 Пфайзер Инк. 2-тиопиримидиноны
PE20180503A1 (es) 2015-05-05 2018-03-09 Pfizer 2-tiopirimidinonas
CN105481839B (zh) * 2015-11-23 2018-05-11 安徽千和新材料科技发展有限公司 一种光活性环氧啉对映体的制备方法
EP3229193A1 (en) 2016-04-07 2017-10-11 The Boeing Company A computer-implemented method and system for sharing information between passengers and air traffic management stakeholders

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910930A (en) * 1973-01-04 1975-10-07 Janssen Pharmaceutica Nv 1-{55 1-{8 2-(1,4-Benzodioxan-2-yl)-2-hydroxyethyl{9 -4-piperidyl{56 -2-benzimidazolinones
DE2400049A1 (de) * 1974-01-02 1975-07-10 Spumalit Anstalt Transportkasten aus kunststoff, insbesondere fuer flaschen
GR71865B (is) 1978-03-20 1983-07-07 Ciba Geigy
US4329348A (en) * 1979-02-26 1982-05-11 Ciba-Geigy Corporation N-Oxacyclic-alkylpiperidines as psychostimulants
EP0144101B1 (en) * 1983-11-30 1991-02-06 Janssen Pharmaceutica N.V. Bicyclic heterocyclyl containing n-(bicyclic heterocyclyl)-4-piperidinamines
SI9300097B (en) * 1992-02-27 2001-12-31 Janssen Pharmaceutica Nv (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines
CA2090767A1 (en) 1992-03-06 1993-09-07 Gerald Guillaumet 1,4-dioxino[2,3-b]pyridine derivatives
US6403103B1 (en) * 1994-08-12 2002-06-11 Bio Merieux Trypanosoma cruzi antigen, gene encoding therefore, and methods of detecting and treating chagas disease
FR2744451B1 (fr) 1996-02-01 1998-04-24 Pf Medicament Nouvelles imidazolidinones, pyrimidinones, et 1,3-diazepin-2 -ones, leur preparation et leurs applications en therapeutique
US6133277A (en) * 1997-12-05 2000-10-17 Janssen Pharmaceutica N.V. (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
CZ20014167A3 (cs) * 1999-06-02 2002-06-12 Janssen Pharmaceutica N. V. Pyrrolidinylem, piperidinylem nebo homopiperidinylem substituované deriváty benzodioxanu, benzofuranu nebo benzopyranu
HUP0201404A3 (en) * 1999-06-02 2005-02-28 Janssen Pharmaceutica Nv Aminoalkyl substituted benzodioxan, benzofuran or benzopyran derivatives, pharmaceutical compositions containing them and their use and process for their preparations
TWI225488B (en) * 1999-12-21 2004-12-21 Janssen Pharmaceutica Nv Derivatives of homopiperidinyl substituted benzimidazole analogues
JO2352B1 (en) * 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus

Also Published As

Publication number Publication date
BG65895B1 (bg) 2010-04-30
ATE312104T1 (de) 2005-12-15
HRP20020988A2 (en) 2005-02-28
JP2004501157A (ja) 2004-01-15
EA200300049A1 (ru) 2003-04-24
CN1288157C (zh) 2006-12-06
HRP20020988B1 (en) 2011-06-30
AR032158A1 (es) 2003-10-29
KR20030007566A (ko) 2003-01-23
CN1781921A (zh) 2006-06-07
UA74576C2 (en) 2006-01-16
DE60115647T2 (de) 2006-08-24
PL201656B1 (pl) 2009-04-30
JO2352B1 (en) 2006-12-12
SK287730B6 (en) 2011-07-06
ES2254467T3 (es) 2006-06-16
AU8386401A (en) 2002-01-02
DE60115647D1 (de) 2006-01-12
HUP0301185A3 (en) 2009-03-30
CA2410233C (en) 2011-01-25
BG107313A (bg) 2003-06-30
MY155267A (en) 2015-09-30
EP1296987A1 (en) 2003-04-02
KR100821107B1 (ko) 2008-04-14
SK492003A3 (en) 2003-07-01
AU783292B2 (en) 2005-10-13
CA2410233A1 (en) 2001-12-27
US7423048B2 (en) 2008-09-09
IL153559A (en) 2008-03-20
NZ522519A (en) 2003-09-26
IS6591A (is) 2002-10-25
SA01220442B1 (ar) 2008-05-21
EP1296987B1 (en) 2005-12-07
NO20026219L (no) 2003-02-17
US20060142318A1 (en) 2006-06-29
US20040019051A1 (en) 2004-01-29
CZ305005B6 (cs) 2015-03-25
BR0111859A (pt) 2003-05-13
EA005760B1 (ru) 2005-06-30
NO328547B1 (no) 2010-03-15
HK1057896A1 (en) 2004-04-23
IS2618B (is) 2010-04-15
CN1437602A (zh) 2003-08-20
WO2001098306A1 (en) 2001-12-27
JP4911860B2 (ja) 2012-04-04
CZ2003115A3 (cs) 2003-06-18
CN100516066C (zh) 2009-07-22
IL153559A0 (en) 2003-07-06
BR0111859B1 (pt) 2015-01-06
PA8519601A1 (es) 2002-08-26
NO20026219D0 (no) 2002-12-23
HU227398B1 (hu) 2011-05-30
EG24462A (en) 2009-07-16
ZA200210303B (en) 2004-03-19
EE200200694A (et) 2004-06-15
MXPA02012844A (es) 2003-05-15
HUP0301185A2 (hu) 2003-08-28
PL358886A1 (en) 2004-08-23
US7081453B2 (en) 2006-07-25

Similar Documents

Publication Publication Date Title
EE04464B1 (et) Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE200300236A (et) 1,2-difenüülasetidinoonid, nende kasutamine, ravim ja selle valmistamismeetod
IL165977A (en) Substituted pyrimidinylaminobenzamides , process for the preparation thereof and pharmaceutical compositions comprising the same
EE200200487A (et) Asetidiini derivaadid, nende valmistamismeetodid ja farmatseutiline kompositsioon
IL230815A (en) Dictopyrazine Compounds, Pharmaceuticals Containing Them and Use in the Treatment of T-Mediated Diseases
EE200200486A (et) Farmatseutilised kompositsioonid, mis sisaldavad 3-aminoasetidiini derivaate, uued derivaadid ja nende valmistamismeetodid
EE200300370A (et) Atsüülitud 6,7,8,9-tetrahüdro-5H-bensotsükloheptenüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat
HUP0300731A3 (en) Valsartan salts, process for their preparation and pharmaceutical compositions thereof
LTPA2014005I1 (lt) Chinazolidino dariniai, minėtus junginius turintys vaistai, jų panaudojimas ir jų gavimo būdas
PL396568A1 (pl) Krystaliczny bursztynian O-demetylo-wenlafaksyny, kompozycja farmaceutyczna, farmaceutyczna postać dawkowania, doustna postać dawkowania, zastosowanie oraz sposób wytwarzania krystalicznego bursztynianu O-demetylo-wenlafaksyny
EE200100431A (et) 16-halogenoepotilooni derivaadid, nende valmistamismeetod ja farmatseutiline kasutamine
HUP0401192A3 (en) Use of photosenzitizing agent for preparation ot, of pharmaceutical composition for treating wounds
IL158289A (en) Mercaptoacetylamide derivatives, a process for their preparation and their use as medicaments for the treatment of hypertension and chf
IL156662A0 (en) Oxazolidinone derivatives, process for the preparation thereof and pharmaceutical compositions containing the same
HUP0301817A3 (en) Kahalalide compounds, process for preparing thereof, pharmaceutical compositions comprising them and their use
EE04878B1 (et) šhendid maop?hja kahjustunud relaksatsiooni raviks, nende valmistamismeetod, farmatseutiline kompositsioon ja selle valmistamismeetod
EE200300537A (et) Meetod madalaannuselise farmatseutilise kompositsiooni tootmiseks
HUP0401747A3 (en) Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds
HUP0303006A3 (en) Retinoids for the treatment of emphysema, process for their preparation and pharmaceutical compositions containing them
PL394600A1 (pl) Związek winyloazacykloalkanowy, sposób jego wytwarzania i jego zastosowanie oraz kompozycja farmaceutyczna
NO326689B1 (no) Pyrrolidinderivater, anvendelse derav, farmasøytisk preparat samt fremgangsmåte for fremstilling av forbindelsene
EE04311B1 (et) Asoolid, nende valmistamismeetod, kasutamine ravimina ja farmatseutiline kompositsioon
HUP0302912A3 (en) Betha-thio-amino acids, process for their preparation and pharmaceutical compositions containing them
HUP0401369A3 (en) Pharmaceutical formulation comprising (r)-bicalutamide, process for its preparation and use thereof
NO20042640L (no) Fremgangsmate for fremstilling av ekinocandinderivater

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20190613